The development of Eudragit® NM-based controlled-release matrix tablets.

Abstract

UNLABELLED Eudragit® NM was investigated as a matrix former in combination with microcrystalline cellulose as an insoluble filler for preparing controlled-release tablets containing model drugs with different solubility. MATERIAL AND METHODS Three sets of matrix tablets differing in the drug-to-filler ratio (1:1, 2:1, and 4:1) and polymer amount with… (More)

Topics

  • Presentations referencing similar topics